Future studies that investigate the role of other chemerin receptors and mechanisms of endogenous chemerin signaling in IBD both more acutely and locally will be important in elucidating the potential of chemerin as a therapeutic target for the treatment of IBD. The gene discussed is CMKLR1; the disease is inflammatory bowel disease.